Skip to main content

Advertisement

Patient delay factors in women presenting with breast cancer in a low income country

Article metrics

  • 1596 Accesses

  • 13 Citations

Abstract

Background

In low income countries, many patients with breast cancer present with advanced disease which is majorly attributed to late presentation and this is associated with poor survival rates. The aim of this study was to determine the magnitude of patient delay and the factors that influence, delay in seeking health care in female breast cancer patients.

Methods

A cross-sectional study was done between January and April 2014 at a tertiary breast unit. Female patients with breast cancer above the age of 18 years were interviewed. Ethical approval was obtained.

Results

In total 162 patients were recruited, the mean patient delay in months was 22.6 (SD = 26.4), median delay was 13 months and range was 1–127 months. 139 (89 %) patients delayed by more than 3 months after noticing symptoms of breast anomaly. Patients with no social support from spouses and family were more likely to delay (OR = 7.1, 95 % CI 2.4–21.5, p = 0.001), those who perceived the symptoms as very serious were less likely to delay (OR = 0.2, 95 % CI 0.1–0.6, p = 0.007). There was a significant association between delayed presentation and advanced stage at presentation (p = 0.006).

Conclusion

Most women (89 %) with breast cancer delayed by more than 3 months to seek the first medical consultation after noticing symptoms. Patients who had no social support from their families were more likely to delay.

Background

Breast cancer is the second commonest non HIV-related cancer among women in Uganda. The majority of women present with advanced disease stage III and IV and the 5 year survival rate in less than 50 % [1]. State provided health care services in Uganda are largely free. However, 50 % of health care services are provided by non government providers and charge a fee for the services. Delayed patient presentation refers to a prolonged interval between discovery of initial symptoms to presentation to a provider and typically defined as greater than 12 weeks as periods longer than this have been associated with poorer survival [2]. Patient delay has been associated with increased tumor size, more advanced stage at presentation and poorer long term survival [3] and is a significant concern in middle and low income countries (LIC).

The association between patient delay and socio-demographic factors, cancer knowledge, family history and other factors has been widely studied [4]. However most of these studies are from the high and middle income countries and similar research focusing on LIC is limited. In Uganda there is only one published research study on this topic [5] and hence the aim of this study was to determine the magnitude and factors that influence patient delay among women with breast cancer.

Methods

A cross-sectional study was carried out at the breast unit of Mulago National Referral Hospital over a period of 4 months between January and April 2014. Female patients 18 years and above with histological diagnoses of breast cancer were consecutively enrolled after written informed consent had been obtained. Patients who were too ill to give sufficient information were excluded from the study.

An adopted interviewer administered structured questionnaire [6] were used to obtain the study variables. This tool was pre-tested and modified before final data collection was done. The variables included in data analysis were: age, occupation, education level, family size, religion, income, marital status, health beliefs, perceptions, knowledge of breast cancer, clinical stage of tumor, social support from spouses and time delays. Social support was taken as the perception and actuality that one is cared for, has assistance available from other people (spouse, relatives and friends) and that one is part of a supportive social network [7]. STATA 12 statistical software was used for data analysis. Univariate analysis was performed on baseline factors and magnitude of patient delay. Logistic regression was used for comparison of variables and significance was when p < 0.05.

Ethical approval was obtained from the Makerere College of Health Sciences Research & Ethics Committee.

Results

The 162 patients studied had a mean age of 45.12 (SD = 11.70), median age of 44 and the peak age category was 35–44. The majority of the patients, 142 (87.7 %) came from rural areas and only 20 (12.3 %) came from an urban setting. 139 (86 %) had clinical stage IV disease and 17 (10 %) had clinical stage III disease. The details of the characteristics of the study participants are shown in Table 1.

Table 1 Characteristics of study participants

78 (48 %) patients perceived the symptoms as nothing serious. 71 (44 %) patients were not worried at the time they first noticed the symptoms of breast cancer, only 12 (7 %) patients sought attention immediately after noticing breast cancer symptoms (see Table 2).

Table 2 Perception of symptoms of breast cancer

The first symptoms noticed were a lump 86 % (139/162), pain 12 % (19/162) and 2 % (4/162) had abnormal discharge. Even through 45 worried a lot about the first symptoms and 46 considered them very seriously; 12 sought attention immediately. The mean patient delay was 22.6 (SD = 26) months. Median delay was 13 months, range was 1–127 months.

The mean patient delay was 22.6 (SD = 26) months. Median delay was 13 months, range was 1–127 months. The majority, 139 (89 %) patients delayed by more than 3 months after noticing symptoms while only 17 (11 %) patients sought attention within 3 months of noticing symptoms of breast cancer (see Table 3).

Table 3 Patient delay categories

Of the 139 who delayed, 123 (88.5 %) presented with stage IV and 13 (9.4 %) stage III. Mean age of 45 (SD = 11.8). Of the 17 who did not delay, 11 (64.7 %) presented with stage IV and 3 (17.7 %) stage III. Mean age of 45.3 (SD = 10.8). There was a significant association between patient delay and lack of social support (OR = 7.12, 95 % CI 2.36–21.46, P = 0.001). There was also a significant association between delayed presentation and advanced stage at presentation (OR = 11.18, 95 % CI 2.01–62.13, P = 0.006), while the association between age, religion, marital status, occupation, education level, monthly income and fear of surgery and patient delay were not significant (see Table 4).

Table 4 The results of logistic regression analysis on patient delay

Discussion

We found out that the overall median delay to the first medical consultation was 13 months. This contrasts with the findings in studies done in the developed countries where median delay to the first medical consultations was found to be 14–61 days [68]. The median delay time to first medical consultation in this study was 13 months which is comparable to the median delay of 12 months reported in a study done in Uganda and published in 2014 [4].

The majority of patients in our study presented 3 months after noticing symptoms most likely because of the way they perceived the ‘seriousness’ of the symptoms, (p = 0.007) which is likely to be based on their awareness (knowledge) of breast cancer. Of the 162 patients studied, 139 (86 %) presented with stage IV disease. This could be due to excessive delay that allowed the progression of the disease to advanced stage and is in agreement with other studies [4, 911]. The advanced stage at presentation could be due to the fact that most cancer in low-and-middle income countries (LMIC) is detected at later stages [12]. It is commonly assumed that this late diagnosis is due to populations’ lack of information and deficient or absent screening programmes. There was a significant association between patient delay and late stage at presentation in the present study. The influence of delay on disease stage is well documented [2, 4].

The patients who lacked social support from family members and spouses were more likely to delay. It is also worth noting that even though 45 took the first cancer symptoms seriously, only less than third 12/45 sought care immediately. This is in keeping with a study done in Mexico in 2011 where it was mentioned that social support is crucial for materialization of the initial contact as well as for the community care [13]. Social support was taken as the perception and actuality that one is cared for, has assistance available from other people (spouse, relatives and friends) and that one is part of a supportive social network [7]. In a context like ours that lacks a comprehensive state welfare benefits, social support becomes even more critical. Several studies have also described how the patient’s concealment of symptoms may influence, delay of medical help-seeking, while discussing them with friends and family can facilitate the decision to seek medical advice [14, 15].

In the current study, patients with knowledge of available services were more likely to delay. This is in contrast with the findings from other studies [10, 1618]. The most likely explanation here is that the likely low level of confidence in the accessibility of the available services.

We also found that patients who interpreted the breast symptoms as cancer were less likely to delay. However, patients who took the symptoms as nothing serious, delayed for more than 3 months. Patients’ interpretation of symptoms as not serious has proved to be strongly associated to patient delay in other quantitative studies in Germany and UK [2, 7].

In this study, only one patient had her breast problem detected through clinical breast examination. This indicates the lack or frequency of clinical breast examination.

Patients who have heard of mammography were less likely to delay in this study. In a study done in Uganda published in 2010, it was mentioned that women in Uganda had little knowledge about mammography probably due to limited mammography services in Uganda [19].

Use of alternative care like herbal medicine with a borderline p value of 0.055 may in part explain some of the delay seen in this study. It has been mentioned in previous studies that strong beliefs in traditional medicine and perhaps strong religious beliefs in LIC were the main reasons for delay in presentation [2022]. In our study nearly half of the patients used herbal medicine prior to seeking conventional hospital based care.

Age, education level, marital status, socioeconomic status, history of breast disease, family history of breast cancer, nature of first symptom had no significant correlation with patient delay. This contrasts with findings from other studies where socio-demographic factors were strongly associated with delay [10, 19], perhaps we needed a larger sample size.

Study limitations

This study was not free of limitations, some participants were not able to remember the exact time of onset of first breast, the time the first medical advice was obtained, the type of health worker first consulted, the date of referral and treatment given. However, calenders were used as an aid to remind patients of the dates accordingly.

Our participants were patients attending the breast clinic at a tertiary hospital in the country capital, hence might not be representative of the Ugandan women population though the demographic analysis reflects the country ethnic mix.

We focused on patient delay factors and not system factors, in some instances, it may be impossible to delink.

Conclusion

Patient delay is a very serious health problem that needs to be addressed urgently in Uganda. The delay was significantly associated with lack of social support from spouses and close family members.

Health education programs regarding breast cancer should address social support, provide more information about the variability of breast cancer symptoms and encourage breast self examination and clinical breast examination.

Another study with a bigger sample size can be done over a longer period of time so that stronger conclusion can be made.

Abbreviations

LIC:

low income countries

LMIC:

low-and-middle income Countries

HIV:

human immunodeficiency virus

References

  1. 1.

    Parkin DM, Ferlay J, Curado MP, et al. Fifty years of cancer incidence: CI5 I-IX. Int J Cancer. 2010;127:2918–27. doi:10.1002/ijc.25517.

  2. 2.

    Ramirez AJ, Westcombe AM, Burgess CC, Sutton S, Littlejohns P, Richards MA. Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet. 1999;353(9159):1127–31.

  3. 3.

    Burgess CC, Ramirez AJ, Richards M, Love SB. Who and what influences delayed presentation in breast cancer? Br J Cancer. 1998;77(8):1343–8.

  4. 4.

    Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353(9159):1119–26.

  5. 5.

    Galukande M, Mirembe F, Wabinga H. Patient delay in accessing breast cancer care in a sub saharan African Country: Uganda. Br J Med Med Res. 2014;4(13):2599–610.

  6. 6.

    Unger-Saldaña K, Peláez-Ballestas I, Infante-Castañeda C. Development and validation of a questionnaire to assess delay in treatment for bresat cancer. BMC Cancer. 2012;12:626.

  7. 7.

    Cooke BD, Rossmann MM, Mc Cubbin HI, Patterson JM. Examining the definition and assessment of social support: a resource for individuals and families. Fam Relat. 1998;37(2):211–6.

  8. 8.

    Arndt V, Sturmer T, Stegmaier C, Ziegler H, Dhom G, Brenner H. Patient delay and stage of diagnosis among breast cancer patients in Germany—a population based study. Br J Cancer. 2002;86(7):1034–40.

  9. 9.

    Meechan G, Collins J, Petrie KJ. The relationship of symptoms and psychological factors to delay in seeking medical care for breast symptoms. Prev Med. 2003;36(3):374–8.

  10. 10.

    Velikova G, Booth L, Johnston C, Forman D, Selby P. Breast cancer outcomes in South Asian population of West Yorkshire. Br J Cancer. 2004;90(10):1926–32.

  11. 11.

    Montazeri A, Ebrahimi M, Mehrdad N, Ansari M, Sajadian A. Delayed presentation in breast cancer: a study in Iranian women. BMC Women’s Health. 2003;3:4.

  12. 12.

    Burgess CC, Potts HWW, Hamed H, Bish AM, Hunter MS, Richards MA, et al. Why do older women delay presentation with breast cancer symptoms? Psycho-Oncology. 2006;15(11):962–8.

  13. 13.

    Gakwaya A, Kigula-Mugambe JB, Kavuma A, Luwaga A, Fualal J, Jombwe J, et al. Cancer of the breast: 5-year survival in a tertiary hospital in Uganda. Br J Cancer. 2008;99(1):63–7.

  14. 14.

    Unger-Saldaña K, Infante-Castañeda C. Is breast cancer delay really the patient’s fault? In: Deng M, Raia F, Vaccarella M, editors. Relational concepts in medicine. 1st edn. Oxford: Interdisciplinary Net; 2011.

  15. 15.

    Burgess C, Hunter MS, Ramirez AJ. A qualitative study of delay among women reporting symptoms of breast cancer. Br J Gen Pract. 2001;51(473):967–71.

  16. 16.

    Smith LK, Pope C, Botha JL. Patients’ help-seeking experiences and delay in cancer presentation: a qualitative synthesis. Lancet. 2005;366(9488):825–31.

  17. 17.

    Hanna T, Kangolle A. Cancer control in developing countries: using health data and health services research to measure and improve access, quality and efficiency. BMC Int Health Hum Rights. 2010;10(1):1–12.

  18. 18.

    Nosarti C, Crayford T, Roberts JV, Elias E, McKenzie K, David AS. Delay in presentation of symptomatic referrals to a breast clinic: patient and system factors. Br J Cancer. 2000;82(3):742–8.

  19. 19.

    Facione NC, Miaskowski C, Dodd MJ, Paul SM. The self-reported likelihood of patient delay in breast cancer: new thoughts for early detection. Prev Med. 2002;34(4):397–407.

  20. 20.

    Kiguli-Malwadde E, Gonzaga Mubuuke A, Businge F, Kawooya M, Nakatudde R, Byanyima KR, et al. Current knowledge, attitudes and practices of women on breast cancer and mammography at Mulago Hospital. Pan Afr Med J. 2010;5(1):4.

  21. 21.

    Rajaram SS, Rashidi A. Asian-islamic women and breast cancer screening: a socio-cultural analysis. Women Health. 1999;28(3):45–58.

  22. 22.

    Clegg-Lamptey J, Dakubo J, Attobra Y. Why do breast cancer patients report late or abscond during treatment in Ghana? A pilot study. Ghana Med J. 2009;43(3):5.

Download references

Authors’ contributions

This work was carried out in collaboration between all authors. Authors OJ and GM originated the concept. Author OJ collected data, performed the data analysis and wrote the first draft. Authors GM, MT and KS performed critical reviews for important intellectual content of the manuscript. All authors agreed to be accountable for all aspects of this work in ensuring questions related to the accuracy or any part of the work are appropriately investigated and resolved. All authors read and approved the final manuscript.

Acknowledgements

Staff at the breast unit and the entire staff at the department of Surgery, Mulago, College of Health Sciences Teaching Hospital.

Funding

This work was self funded.

Compliance with ethical guidelines

Competing interests The authors declare that they have no competing interests.

Author information

Correspondence to M. Galukande.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Keywords

  • Patient delay
  • Breast cancer
  • Advanced disease